Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study

Purpose: Combined radiotherapy (RT) and immune checkpoint-inhibitor (ICI) therapy can act synergistically to enhance tumor response beyond what either treatment can achieve alone. Alongside the revolutionary impact of ICIs on cancer therapy, life-threatening potential side effects, such as checkpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Spieler, Benjamin, Giret, Teresa M., Welford, Scott, Totiger, Tulasigeri M., Mihaylov, Ivaylo B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138533/
https://www.ncbi.nlm.nih.gov/pubmed/35625911
http://dx.doi.org/10.3390/biomedicines10051173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138533/
https://www.ncbi.nlm.nih.gov/pubmed/35625911
http://dx.doi.org/10.3390/biomedicines10051173

Ejemplares similares